- Home
- CCO vs KOD Comparison
CCO vs KOD Comparison
Compare CCO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- KOD
- Stock Information
- Founded
- CCO 1995
- KOD 2009
- Country
- CCO United States
- KOD United States
- Employees
- CCO N/A
- KOD N/A
- Industry
- CCO Advertising
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCO Consumer Discretionary
- KOD Health Care
- Exchange
- CCO Nasdaq
- KOD Nasdaq
- Market Cap
- CCO 899.6M
- KOD 795.5M
- IPO Year
- CCO 2005
- KOD 2018
- Fundamental
- Price
- CCO $1.80
- KOD $18.56
- Analyst Decision
- CCO Hold
- KOD Buy
- Analyst Count
- CCO 5
- KOD 7
- Target Price
- CCO $2.13
- KOD $19.29
- AVG Volume (30 Days)
- CCO 4.4M
- KOD 968.0K
- Earning Date
- CCO 11-06-2025
- KOD 11-13-2025
- Dividend Yield
- CCO N/A
- KOD N/A
- EPS Growth
- CCO N/A
- KOD N/A
- EPS
- CCO 0.04
- KOD N/A
- Revenue
- CCO $1,538,895,000.00
- KOD N/A
- Revenue This Year
- CCO $6.16
- KOD N/A
- Revenue Next Year
- CCO $4.01
- KOD N/A
- P/E Ratio
- CCO $40.92
- KOD N/A
- Revenue Growth
- CCO 31.61
- KOD N/A
- 52 Week Low
- CCO $0.81
- KOD $1.92
- 52 Week High
- CCO $2.03
- KOD $21.17
- Technical
- Relative Strength Index (RSI)
- CCO 57.52
- KOD 57.84
- Support Level
- CCO $1.75
- KOD $16.25
- Resistance Level
- CCO $2.03
- KOD $21.17
- Average True Range (ATR)
- CCO 0.12
- KOD 1.87
- MACD
- CCO -0.00
- KOD 0.08
- Stochastic Oscillator
- CCO 64.71
- KOD 69.40
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.